The Flume Catheter Company Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

The Flume Catheter Company Inc. - overview

Established

2016

Location

Salt Lake City, UT, US

Primary Industry

Medical Devices & Equipment

About

The Flume Catheter Company Inc. , based in the US, specializes in innovative urinary catheter solutions, enhancing patient comfort and reducing complications associated with traditional catheters. Founded in 2016 in Salt Lake City, US, The Flume Catheter Company Inc. develops advanced urinary catheters.


The company has conducted a single deal, raising EUR 1. 4 million in an Angel funding round on August 29, 2024, aimed at supporting its innovation efforts. The founder's information is not provided. The Flume Catheter Company specializes in the design and manufacture of innovative urinary catheters, with its flagship product being the patented FLUME® catheter.


This catheter addresses significant shortcomings in traditional designs that have not evolved since the 1930s, aiming to enhance patient comfort and reduce complications such as infections and blockages. The FLUME® catheter features a flexible balloon that contacts the bladder, eliminating the discomfort caused by a rigid tip, while its inset drainage holes are strategically located at the base of the balloon to prevent obstruction and infection. Designed for ease of use, it employs the same insertion and removal technique as conventional Foley catheters. The company caters to a broad client base, including healthcare providers, hospitals, and clinics across the United States and other international markets, with recent expansions to include Suprapubic options and larger balloon sizes.


The Flume Catheter Company generates revenue primarily through direct sales of its FLUME® catheter and associated products to healthcare facilities and clinicians. The transaction structure involves B2B sales, where clinicians and hospitals order the catheters based on patient needs and feedback. Pricing details for the FLUME® catheter and its variations are established based on the product's advanced features and quality assurances. Given the focus on improving patient outcomes, healthcare providers are incentivized to adopt the FLUME® catheter in place of traditional options, fostering ongoing partnerships.


The company has established collaborations with a world-class manufacturer, Well Lead, ensuring that quality remains a cornerstone of its operational and revenue-generating strategies. The Flume Catheter Company Inc. plans to utilize the EUR 1. 4 million raised in Angel funding in August 2024 to drive the development of new catheter designs and enhance its product line.


The company aims to expand into additional markets within Europe and Asia by the end of 2025, focusing on regions with high demand for advanced urinary catheter solutions.


Primary Industry

Medical Devices & Equipment

Sub Industries

Surgical Devices

Website

www.flumecatheter.com/

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.